对抗COVID-19的草药组合:一个网络药理学,分子对接和动力学研究的研究
Jian-Bo Song1, Li-Qin Zhao2, Hong-Ping Wen1
1Department of Pharmacy, the Fifth Affiliated Hospital of Shanxi Medical University (Shanxi Provincial People's Hospital), Taiyuan 030012, Shanxi Province, China.
Journal of integrative medicine
|October 7, 2023
概括
这项研究确定了阿米格达卢斯·共产主义的传统中医组合,埃菲德拉·赫巴和Scutellaria baicalensis对COVID-19有效. 拜卡莱因显示出作为对抗SARS-CoV-2及其变种的治疗剂的潜力.
科学领域:
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 传统中医 (TCM) 为传染病提供了潜在的治疗策略.
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 和其变种构成了全球重大健康挑战.
- 从自然来源识别新型抗病毒剂对于对抗病毒感染至关重要.
研究的目的:
- 识别传统中医药 (TCM) 中的分子,对抗SARS-CoV-2及其变体具有潜在的活性.
- 探索特定的TCM草药组合在治疗2019年新冠肺炎疾病 (COVID-19) 的有效性.
- 研究TCM组件抗病毒活性背后的分子机制.
主要方法:
- 预先算法用于识别关键的TCM草药组合.
- 网络药理学探索活性成分和核心目标.
- 分子对接和动力学模拟以评估化合物-蛋白相互作用和稳定性.
主要成果:
- 杏仁 (Amygdalus Communis Vas.) 草 (Ephedra Herba) 和白草 (Scutellaria baicalensis) 的组合被确定为COVID-19治疗的重要草药组合.
- 确定了11种活性化合物,包括贝卡莱因,卢托林和纳灵宁,具有20个核心目标.
- 拜卡莱因表现出强烈的结合亲和力,并干扰了SARS-CoV-2尖端蛋白-ACE2受体相互作用,在模拟过程中显示稳定性.
结论:
- 确定了A. communis,Ephedra Herba和S. baicalensis的草药组合,可以为COVID-19治疗提供希望.
- 拜卡莱因成为抗击SARS-CoV-2及其不断发展的变种的潜在治疗候选者.
- 这项研究强调了将计算方法与传统医学的药物发现整合的力量.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Structure-Activity Relationships and Drug Design
742
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
742
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K


